Enveric Biosciences Inc vs MakeMyTrip Ltd — how do they compare? Enveric Biosciences Inc trades at $1.56 (market cap $6.20M), while MakeMyTrip Ltd trades at $60.7 (market cap $5.78B). The key difference: MakeMyTrip Ltd is far larger — about 932.3× Enveric Biosciences Inc's market cap, and MakeMyTrip Ltd is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | MMYT | |
|---|---|---|
Market Cap | $6.20M | $5.78B |
Sector | Health | Technology |
52-Week High | $17.40 | $103.21 |
52-Week Low | $1.27 | $36.30 |
Enterprise Value | $1.30M | $6.44B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MakeMyTrip (MMYT) trades at $60.70, down 0.34% with a bullish technical signal supported by moving averages. The company reported strong Q1 2027 earnings with revenue growth in hotels and packages offsetting air-ticketing softness. Analysts maintain a 72.7% buy rating with a 34.1% upside target. Recent financials show $978M revenue and $95M net income for 2025, though 2026 projections indicate margin compression.
The stock presents growth potential driven by travel recovery and platform diversification, but faces risks from geopolitical disruptions, fuel costs, and rising debt levels. Current valuation metrics (P/E 267, P/S 6.07) suggest premium pricing requiring sustained execution. Institutional sentiment remains positive despite recent selling by Boston Common Asset Management.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →